- CEO
- Jiang Li
- Full Time Employees
- 5,924
- Sector
- Process industries
- Industry
- Chemicals: agricultural
- Address
- Mianyang Eco Technical Dev Zone Chengdu SI China 621000
- IPO Date
- Jul 9, 2008
- Business
- Lier Chemical Co., Ltd. (002258.SZ) engages in the research, development, production, and sale of high-efficiency, low-toxicity, low-residue pesticides and chemical intermediates primarily for the agricultural sector in China and internationally. Founded in 1993 and headquartered in Mianyang Economic and Technological Development Zone, Sichuan Province, China, with additional facilities in Shanghai and Guang'an Lier Chemical Co., Ltd., a wholly-owned subsidiary, the company offers herbicides such as glyphosate, glufosinate-ammonium, diquat, flumioxazin, clodinafop-propargyl, clopyralid, picloram, fluroxypyr-meptyl, triclopyr, aminopyralid, pinoxaden, diuron, bensulfuron-methyl, linuron, pyrazosulfuron-ethyl, nicosulfuron, flufenacet, mefenacet, and quinclorac; fungicides including prothioconazole, azoxystrobin, epoxiconazole, iprodione, and difenoconazole; insecticides comprising chlorantraniliprole, chlorpyrifos, and pyriproxyfen; and intermediates such as 2-chloropyridine, 2,3-dichloropyridine, 2,5-dichloropyridine, 2,6-dichloropyridine, 2,3,4-trichloropyridine, 6-chloropyridine-2-carbonitrile, 3,6-difluoropyridine-2-carboxylic acid, and others. The company exports to over 30 countries and regions, including the United States, Brazil, Argentina, Australia, Canada, and India, with international sales accounting for 47% of revenue in 2024, and maintains long-term strategic cooperative relationships with global agrochemical leaders such as BASF SE and Corteva. Recent developments include plans to raise RMB 2.088 billion for a 10,000 t/a glufosinate technical production line and chloropyridine industry chain consolidation; investments in Guang'an Lier Chemical for 3,000 t/a pesticide intermediates, a 30,000-ton chloropyridine project with RMB 550 million total investment, and a RMB 980 million 10,000-ton glufosinate project; technical upgrading of chloropyridines production lines; and an earlier partnership with Nufarm for glufosinate supply, alongside expectations of nearly doubled net income in the first half of 2025 driven by volume and price increases in select products.